How to Ensure Process Consistency When Scaling ODF from Lab to Mass Production

Many Oral Dissolvable Film (ODF) projects pass laboratory validation, yet struggle at pilot or commercial scale. Symptoms include shifts in film properties, content drift, abnormal drying, and falling yields. The underlying cause is often a loss of process consistency during scale-up. Achieving seamless migration from lab to mass production depends on equipment controllability and module reusability.

Common Control Gaps During ODF Scale-Up

• Unstable liquid feed: manual dripping in the lab vs. closed-loop pumping in production
• Large tension swings: wider web widths amplify uneven tension, causing wrinkles or breaks
• Uneven drying: long hot-air paths at scale lead to localized overheating or under-drying
• Inconsistent thickness: lack of in-line thickness monitoring hides edge-to-center variation

How to Achieve “Steady-State” Scale-Up

• Choose equipment with a controllable slot-die (coating die) and automatic tension control to maintain constant web tension across stages.
• Apply a gradient hot-air drying design to prevent stress shocks that degrade film performance.
• Integrate in-line thickness measurement (e.g., IR or laser) to dynamically correct coat weight.
• Implement digital parameter management—capture, record, and export data to enable cross-stage comparison and traceability.

Recommended equipment and pages:

• MJ150-L Precision Pilot Coating System
• In-Line Thickness Monitoring System
• Related Pharmaceutical Testing Instruments

HUANGHAI’s Process-Consistency Control Approach

• Unified architecture: R&D, pilot, and production platforms share the same slot-die + airflow path principles to ensure parameter portability.
• System-level feedback: closed-loop tension feedback and constant-feed mechanisms stabilize the entire process.
• Data modules: optional data acquisition enables cross-batch and cross-stage traceability.
• Manufacturing–testing loop: integrate dissolution/thickness testing with the main line to close the feedback loop.

Conclusion

Scaling ODF is not “just switching equipment”—it is about reusing proven process experience at larger scales. A highly consistent, verifiable equipment platform is the decisive foundation for commercial ODF production.

*Features Huanghai's exclusive patented hot-air drying technology (Patent No. CN201668734U) ensuring uniform bottom-up heating.

---

Frequently Asked Questions

Q: What is the difference between an ODF film and a transdermal patch?

A: Oral Dissolving Films (ODF) are placed on or under the tongue and dissolve within seconds to minutes, delivering APIs directly through the oral mucosa or via swallowing. Transdermal patches adhere to the skin and deliver APIs through the dermal layers into systemic circulation over hours to days. Despite different delivery routes, both are manufactured using similar solvent-cast film coating processes. Huanghai's MJ150 ODF machine supports both applications on a single platform with approximately 2 working days of changeover time.

Q: What production output can I expect from a Huanghai ODF machine?

A: The MJ150 produces 20,000 films/hour at commercial scale. The MJ150-L targets R&D and pilot production at 8,000–10,000 films/hour. For fully integrated lines, pair either machine with the MJF180 automatic cutting and packaging system (11,900 films/hr) or the more affordable EZ320 (9,000 films/hr). A complete MJ150 + MJF180 line can produce over 150 million finished pouches annually on a single-shift basis. Contact us for pricing and configuration details.

Q: What drying technology does Huanghai use for ODF production?

A: Huanghai uses patented gradient hot-air drying (Patent CN201668734U), which applies a smooth progressive temperature drop rather than stepwise oven zones used by competitors. This results in more uniform film thickness, reduced edge curl, and better API distribution across the film web. An optional far-infrared heating module adds 20–30% drying efficiency for solvent-based formulations. This patented drying system is one of the key technical advantages that justifies Huanghai's position as the preferred ODF equipment supplier to Sinopharm, Shanghai Pharma, and Fosun Pharma.

Q: What are the GMP requirements for ODF production equipment?

A: ODF manufacturing equipment must comply with cGMP (21 CFR Parts 210/211) for US market products, and equivalent standards (EU GMP Annex 1, ChGMP) for other markets. Key requirements: material contact surfaces must be 316L stainless steel or equivalent; CIP/SIP capability or documented cleaning validation; data integrity controls meeting ALCOA+ principles (audit trails, access control). Huanghai ODF machines meet these standards—all product contact surfaces use pharmaceutical-grade materials, and the control system includes operator access logs and parameter change records. Request our GMP compliance documentation.

For a full overview of the certifications and compliance standards our equipment meets, see our Certifications & Compliance page.

Q: Can Huanghai machines produce stripe-coated or multi-formula ODF films?

A: Yes. Huanghai holds a patent for multi-formula stripe coating (Patent CN117323228A), enabling two different API formulations to be applied side-by-side in a single coating pass. This eliminates the need for multiple coating/drying cycles when producing combination-drug ODF products. Competitors require manual multi-layer coating with drying intervals between each formula. This capability is particularly valuable for fixed-dose combination products (e.g., dual-API ODFs for cardiovascular or CNS indications) where coating efficiency directly impacts production economics.